Dr. Mohapatra is experienced in diagnostics, therapeutic intervention, radiation safety and tele-radiologic reporting, with a special interest in F-18, FDG, PET-CT studies for oncology, cardiology, neurology indications, PET-based radiation therapy planning, I-131 therapy in thyroid cancer and benign thyroid diseases, Rhenium-188 for synovectomy and Samarium therapy for bone pain palliation.
Dr. Mohapatra is actively involved in performing procedures like SISCOS and SISCOM on epilepsy patients.
Dr. Mohapatra has attended more than 40000 cases so far.
Dr. Mohapatra is also a lifetime member of the Society of Nuclear Medicine, India (SNMI) (M-72), and the World Federation of Nuclear Medicine and Biology (WFNMB).
(18)F-FDG PET/CT for initial assessment and response monitoring in a case of high-grade primary lymphoma of the thyroid gland: A case report and review of the literature. Indian J Nucl Med. 2014 Apr;29(2):94-6.
Coexisting iodine avid and iodine non-concentrating lesions with multiple distant soft tissue metastasis in papillary thyroid cancer. Indian J Nucl Med. 2012 Jan;27(1):38-41.
Primary penile lymphoma: the use of PET-CT for accurate staging and response monitoring. Diagn Interv Radiol. 2013 Mar-Apr;19(2):130-3.
A rare case of mature teratoma. Has FDG PET/CT a role to play? Indian J Nucl Med. 2011 Apr;26(2):107-8.
Increased renal corticomedullary FDG activity in a patient of NHL-malignant or benign? Indian J Nucl Med. 2010 Oct;25(4):178.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.